transforming drug discovery

Sequence Bio is a Newfoundland and Labrador company planning to lead a 100,000 person genome sequencing project. By unlocking transformative insights into human biology, we can improve how we treat diseases and develop medicines. But we can't do it alone...

why newfoundland and labrador?

there's nowhere quite like it

Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador. That's why we know the opportunity to advance health care and medicine is right here at home.

Icon isolated

unique isolated population

Icon desease

high incidence of rare and complex diseases

Icon electronic records

comprehensive electronic health records

Icon family

extended family pedigrees

the 100k genome project

improving healthcare and drug discovery here at home

The 100k Genome Project will be a community-based initiative enabling innovative science and improving the healthcare for the people of Newfoundland and Labrador.

Partnership Opportunities

a life-changing approach

By pairing powerful computational approaches with integrated human patient data, Sequence Bio offers transformative insights into human biology, leading to novel therapeutics. We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!

inquire about partnerships

Our Partners
Gov nl
Genome atlantic
The Sequence Crew

meet the team

We're a happy mix from all across Newfoundland and Labrador, with a higher than average affinity for ping-pong. Our kitchen always has some fresh Tetley on the boil and Jam Jam cookies in the cupboard. Get to know us a little more by clicking on our lovely mugs!

We're hiring, join the team

Tyler Wish

CEO, Founder

Chris Gardner

COO, Founder

Jeremy Grushcow

Chief Business Officer

Karen Moores

VP External Affairs

Sophie Harrington

Director of Marketing

Neala Quigley

Director of Community Engagement

Dan Brake

Director of Technology

Angela Power

Director of Privacy and Policy

Meshari Alwashmi

Research Coordinator

Matt Stenback

User Experience Lead

Diane Power

Project Manager, Research Operations


Chief Indifference Officer

Advised by the brightest minds

scientific advisory board

Dr. Euan Ashely

Stanford Medicine

Dr. Pek Lum

Capella Bio

Sequence Bio leadership

board of directors

Chris Gardner

Sequence Bio

Tyler Wish

Sequence Bio

Mark Dobbin

Killick Capital

Andrew Furey

team broken earth

James Hardiman